123 related articles for article (PubMed ID: 11014367)
1. Apolipoprotein(a) deposition in atherosclerotic coronary arteries of a patient with systemic lupus erythematosus: comment on the article by Romero et al.
Asanuma Y; Kawai S
Arthritis Rheum; 2000 Sep; 43(9):2141-2. PubMed ID: 11014367
[No Abstract] [Full Text] [Related]
2. Potential effects of cyclosporin A on coronary vasomotor function in young patients with systemic lupus erythematosus: comment on the article by Hirata et al.
Korkmaz C
Arthritis Rheum; 2008 Jan; 58(1):330-1; author reply 331. PubMed ID: 18163479
[No Abstract] [Full Text] [Related]
3. The risk of cardiac events among patients with systemic lupus erythematosus: comment on the article by Costenbader et al.
Jolly M
Arthritis Rheum; 2005 Jun; 53(3):476. PubMed ID: 15934113
[No Abstract] [Full Text] [Related]
4. Low bone density and vertebral fractures in systemic lupus erythematosus: comment on the article by Bultink et al.
Constantinescu F; DeMarco PJ
Arthritis Rheum; 2006 Jan; 54(1):378-9; author reply 379. PubMed ID: 16385532
[No Abstract] [Full Text] [Related]
5. Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood: comment on the article by Brunner et al.
Taher A; Badreddine R; Deeb J; Uthman I
Arthritis Rheum; 2002 May; 46(5):1410. PubMed ID: 12115255
[No Abstract] [Full Text] [Related]
6. Antiphospholipid syndrome nephropathy in antiphospholipid antibody-positive patients with systemic lupus erythematosus: comment on the article by Tektonidou et al.
Korkmaz C
Arthritis Rheum; 2005 Mar; 52(3):988-9; author reply 989-90. PubMed ID: 15751054
[No Abstract] [Full Text] [Related]
7. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus: comment on the article by Efthimiou et al.
Zhang HL; Qin GX; Fan ZY; Wu J
Arthritis Rheum; 2011 Jan; 63(1):309; author reply 309-10. PubMed ID: 20848565
[No Abstract] [Full Text] [Related]
8. Immunohistochemical detection of apolipoprotein A-I and B-100 in canine atherosclerotic lesions.
Sako T; Uchida E; Kagawa Y; Hirayama K; Nakade T; Taniyama H
Vet Pathol; 2003 May; 40(3):328-31. PubMed ID: 12724575
[TBL] [Abstract][Full Text] [Related]
9. Coronary artery angiography in systemic lupus erythematosus patients with abnormal myocardial perfusion scintigraphy.
Sella EM; Sato EI; Barbieri A
Arthritis Rheum; 2003 Nov; 48(11):3168-75. PubMed ID: 14613279
[TBL] [Abstract][Full Text] [Related]
10. [Systemic lupus erythematosus and pulmonary fibrosis].
Medicina (B Aires); 2002; 62(2):176-80. PubMed ID: 12043706
[No Abstract] [Full Text] [Related]
11. Is acquired C1 inhibitor deficiency associated with lupus a distinct disease entity? Comment on the article by Cacoub et al.
Aslam A; Misbah SA
Arthritis Rheum; 2002 Oct; 46(10):2827-8; author reply 2828. PubMed ID: 12384953
[No Abstract] [Full Text] [Related]
12. Association of antioxidized low-density lipoprotein antibodies with vascular arterial events and renal manifestations in systemic lupus erythematosus patients: comment on the article by Frostegård et al.
Bertoli AM; Fernández M; McGwin G; Vilá LM; Reveille JD; Alarcón GS;
Arthritis Rheum; 2006 Jun; 54(6):2035-6. PubMed ID: 16732576
[No Abstract] [Full Text] [Related]
13. Premature coronary disease in systemic lupus.
Violi F; Loffredo L; Ferro D
N Engl J Med; 2004 Apr; 350(15):1571-5; author reply 1571-5. PubMed ID: 15074010
[No Abstract] [Full Text] [Related]
14. Osteoporosis, vitamin D deficiency, and supplementation in juvenile systemic lupus erythematosus: comment on the article by Compeyrot-Lacassagne et al.
Praprotnik S; Tomsic M
Arthritis Rheum; 2007 Dec; 56(12):4228; author reply 4228-9. PubMed ID: 18050257
[No Abstract] [Full Text] [Related]
15. Soluble CD154 is not associated with atherosclerosis in systemic lupus erythematosus.
Kiani A; Mahoney JA; Petri M
J Rheumatol; 2007 May; 34(5):969-72. PubMed ID: 17407217
[TBL] [Abstract][Full Text] [Related]
16. Exacerbation of systemic lupus erythematosus after hepatitis B vaccination: comment on the article by Battafarano et al and the letter by Senécal et al.
Maillefert JF; Tavernier C; Sibilia J; Vignon E
Arthritis Rheum; 2000 Feb; 43(2):468-9. PubMed ID: 10693893
[No Abstract] [Full Text] [Related]
17. Pertinence of cardiovascular disease risk awareness in adolescent patients with systemic lupus erythematosus: comment on the article by Scalzi et al.
Bidwell C; Bolt I; McDonagh JE
Arthritis Rheum; 2008 Dec; 58(12):3971-2; author reply 3972. PubMed ID: 19035507
[No Abstract] [Full Text] [Related]
18. Additional components to measuring fatigue in patients with systemic lupus erythematosus: comment on the article by the Ad Hoc Committee on systemic lupus erythematosus response criteria for fatigue.
Wallace DJ
Arthritis Rheum; 2008 Jul; 59(7):1049; author reply 1049-50. PubMed ID: 18576308
[No Abstract] [Full Text] [Related]
19. Roles of nucleosomes in systemic lupus erythematosus: comment on the article by Amoura et al.
Lee SL
Arthritis Rheum; 1999 Dec; 42(12):2733-4. PubMed ID: 10616030
[No Abstract] [Full Text] [Related]
20. Oxidative stress in systemic lupus erythematous: comment on the article by Wang et al.
Stein CM
Arthritis Rheum; 2010 Dec; 62(12):3835-6. PubMed ID: 20737468
[No Abstract] [Full Text] [Related]
[Next] [New Search]
